Analyst Ratings for Kindred Biosciences (KIN) [Buys]
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 2 / 10
Percentile Rank: 15%
Rating Score: 2 / 10
Percentile Rank: 15%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/11/2019 | Barclays » Updated 11/14/2019 |
Balaji Prasad | New Coverage | Overweight (N/A) |
12.00 (N/A) |
8.01 (9.25) |
15.48% | Details |
| 5/23/2019 | Stifel » Updated 5/12/2021 |
Jonathan Block | New Coverage | Buy (N/A) |
9.00 (11.00) |
8.29 (9.25) |
11.58% | Details |
 |
||||||||
